Hydrogen Sulfide from Brain Protein: Alzheimer's Treatment Hope

Scientists at Johns Hopkins Medicine have announced that a recent study funded by the National Institutes of Health is paving the way for an innovative treatment strategy against Alzheimer's disease. At the heart of this research lies a specific brain protein responsible for generating a minute yet

This protein, known scientifically as Cystathionine γ-lyase or CSE, is primarily recognized for its role in producing hydrogen sulfide—the pungent gas reminiscent of rotten eggs. Emerging evidence suggests that CSE plays a pivotal part in the mechanisms underlying memory formation. These insights stem from rigorous experiments conducted on genetically modified mice, as detailed by Bindu Paul, M.S., Ph.D., who serves as an associate professor in the departments of pharmacology, psychiatry, and neuroscience at the Johns Hopkins University School of Medicine.

Detailed in the prestigious Proceedings of the National Academy of Sciences, this investigation seeks to elucidate the precise functions of the CSE protein and explore whether enhancing its activity might safeguard neuronal cells while potentially decelerating the advancement of neurodegenerative conditions like Alzheimer's.

Hydrogen Sulfide's Potential to Safeguard Neurons

Prior investigations have indicated that hydrogen sulfide possesses neuroprotective qualities in mouse models. Nevertheless, its inherent toxicity at elevated concentrations renders direct administration to the brain hazardous. Researchers are therefore concentrating on strategies to sustain the trace amounts of this gas that occur naturally within neurons in a safe manner.

The latest discoveries reveal that mice genetically engineered without the CSE enzyme exhibit significant deficits in memory and learning capabilities. Moreover, these animals display heightened oxidative stress, elevated DNA damage, and compromised integrity of the blood-brain barrier—pathological hallmarks that closely mirror those observed in Alzheimer's disease, according to Paul, the principal author of the study.

Expanding Upon Decades of Foundational Work

This recent endeavor builds upon a substantial body of prior research spearheaded by Solomon Snyder, M.D., D.Sc., D.Phil., a distinguished professor emeritus in neuroscience, pharmacology, and psychiatry. Back in 2014, his team demonstrated that CSE was essential for maintaining brain health in mice afflicted with Huntington's disease. The foundational mouse models lacking the CSE protein were initially created in 2008, following discoveries that linked the protein to vascular function and the regulation of blood pressure.

In 2021, the research collective observed dysfunctional CSE activity in Alzheimer's model mice, noting that minuscule doses of hydrogen sulfide injections could preserve cerebral functionality. While those earlier projects examined mice with superimposed genetic alterations associated with neurodegeneration, the current study meticulously isolates the independent contributions of CSE itself.

"Our newest findings underscore that CSE independently exerts a profound influence on cognitive processes, opening promising therapeutic corridors for Alzheimer's interventions," remarked Snyder, the co-corresponding author, who stepped down from the Johns Hopkins Medicine faculty in 2023.

Deficiency in CSE Directly Tied to Memory Impairment

To delve deeper into CSE's impact on memory, the team contrasted genetically CSE-deficient mice with their wild-type counterparts from the same 2008 strain. Spatial memory—encompassing the capacity to recall paths and respond to environmental cues—was evaluated via the Barnes maze apparatus.

In the Barnes maze protocol, rodents are trained to evade an aversive bright light by navigating to a concealed escape chamber. At the two-month mark, both CSE-intact and CSE-knockout mice demonstrated comparable proficiency, successfully identifying the shelter in under three minutes. However, by six months of age, the mice devoid of CSE faltered markedly in locating the exit, whereas normal mice maintained their navigational prowess.

"This progressive deterioration in spatial memory signifies the gradual emergence of neurodegenerative pathology directly attributable to CSE absence," explained Suwarna Chakraborty, the lead author and a key researcher in Paul's laboratory.

Cerebral Alterations Echo Alzheimer's Pathology

Further analyses probed the cellular repercussions of CSE depletion in the brain. The hippocampus, indispensable for learning and memory consolidation, depends on ongoing neurogenesis—the birth of new neurons. Impairments in neurogenesis represent a well-documented aspect of various neurodegenerative disorders.

Employing sophisticated biochemical assays and analytical techniques, the investigators detected diminished or absent levels of neurogenesis-associated proteins in CSE-deficient mice.

Advanced electron microscopy unveiled profound structural anomalies in the brains of these mice, including extensive disruptions in vascular integrity that signal blood-brain barrier dysfunction—a classic indicator of Alzheimer's. Additionally, nascent neurons struggled to migrate effectively to the hippocampus, hindering their typical role in bolstering memory circuits.

"CSE-deficient mice exhibited multifaceted vulnerabilities across cellular and structural domains, aligning precisely with Alzheimer's clinical manifestations," noted Sunil Jamuna Tripathi, co-first author and lab researcher under Paul.

Pioneering Therapies for Alzheimer's

In the United States alone, Alzheimer's impacts over 6 million individuals, per data from the U.S. Centers for Disease Control and Prevention, with prevalence steadily rising. To date, no pharmacological interventions have reliably halted or mitigated the disease's relentless course.

The study team posits that modulating CSE and its hydrogen sulfide output could herald novel therapeutic avenues, focused on preserving neural integrity and impeding pathological progression.